Exo news

The device-agnostic software seamlessly integrates with hospital IT for streamlined documentation, billing and QA management all in one platform

REDWOOD CITY, Calif. (March 9, 2022) — Exo (pronounced “echo”), a pioneering health information and devices company, has unveiled Exo Works™, an intelligent and intuitive point-of-care ultrasound workflow solution that enables physicians to easily document,

Exo continues to be recognized as a pioneer in health information and medical imaging with CB Insights recently naming Exo to its Digital Health 150 List of the most promising, private digital health companies in the world. CB Insights develops software that enables digital health companies to manage end-to-end technology to make decision-making processes more efficient.

“This recognition by CB Insights is deeply rewarding as our company continues to reinvent the way physicians

President of Cardinal Health at-Home, Suzanne Foster, joins Exo board of directors as leadership team also expands.

REDWOOD CITY, Calif. (Nov. 3, 2021) — Following a successful $220 million Series C funding round, pioneering health information and devices company Exo (pronounced “echo”) is expanding its board of directors and adding key industry leaders to its management team to carry out its mission of taking medical imaging everywhere.

Suzanne

Exo will commercialize an affordable handheld ultrasound device and workflow platform for a new era of medical care

REDWOOD CITY, Calif. (July 29, 2021) — Exo (pronounced “echo”), a pioneering health information and devices company, closed a $220 million Series C investment round led by RA Capital Management and joined by BlackRock, Sands Capital, Avidity Partners and Pura Vida Investments that will fund